Key result
Remimazolam anesthesia enables stable hemodynamics and immediate extubation without complications in a pediatric Fontan case.
Why the study?
The Fontan procedure requires anesthetics that allow rapid awakening and minimal circulatory depression, but the use of remimazolam in this procedure had not been reported.
Is remimazolam a feasible and safe sedative option during the Fontan procedure?
Is remimazolam a feasible and safe sedative option during the Fontan procedure?
Remimazolam may be a feasible and safe sedative option for general anesthesia during the Fontan procedure, allowing for stable hemodynamics and early extubation.
Answers are grounded in this paper and cite their sources.
May support remimazolam feasibility in pediatric Fontan cases; hypothesis-generating and requires prospective trials before adoption.
The Fontan procedure requires anesthetics, allowing rapid awakening for early extubation and less circulatory depression owing to passive pulmonary blood flow hemodynamics. Remimazolam, a short-acting benzodiazepine, may be a suitable anesthetic choice; however, its use in this procedure is unreported. We present a 2-year-old boy with a single-right ventricle and pulmonary valve stenosis who underwent the Fontan procedure under anesthesia with remimazolam (3–8 mg kg − 1 h − 1 ) and fentanyl (21.8 μg/kg). Hemodynamics remained stable under electroencephalographic monitoring, and the patient was extubated in the operating room without any complications. Therefore, remimazolam may be a feasible sedative option during the Fontan procedure.
No takes yet. Share an insight, caveat, or question.
Shimizu et al. (2026) studied this question. Remimazolam anesthesia enabled stable hemodynamics and successful immediate extubation without complications in a 2-year-old undergoing the Fontan procedure.
Synapse has enriched 10 related papers. Consider them for comparative context: